ROLE OF LUTETIUM-177 RADIOLABELED SMALL MOLECULE TARGETING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AN EARLY TREATMENT OPTION IN PROSTATE CANCER